Zobrazeno 1 - 10
of 147
pro vyhledávání: '"MC Bene"'
Autor:
Alain Bernard, B David, Evelyne Racadot, Lydia Campos, Eric Lepage, C Sebban, Claude Boucheix, H Jouault, F Sigaux, MC Bene
Publikováno v:
Europe PubMed Central
The aim of the multicentric trial LALA87 was to test the efficacy of different postremission therapies in adults (15 to 60 year olds) with acute lymphoblastic leukemia (ALL). An immunologic subclassification based on surface marker expression was pro
Autor:
MC Bene
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Review on M0 acute non lymphocytic leukemia (M0-ANLL), with data on clinics, and the genes involved.
Autor:
Mc, Bene, Bernier M, René-Olivier Casasnovas, Castoldi G, Knapp W, Lanza F, Wd, Ludwig, Matutes E, Orfao A, Sperling C, Veer Mb, T.
Publikováno v:
Europe PubMed Central
We document findings on c-kit (CD117) expression in 1,937 pediatric and adult de novo acute leukemia cases, diagnosed in five single European centers. All cases were well characterized as to the morphologic, cytochemical, and immunologic features, ac
Autor:
Kern W; MLL Munich Leukemia Laboratory, Munich, Germany., Westers TM; Department of Hematology, Amsterdam University Medical Centers, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Bellos F; MLL Munich Leukemia Laboratory, Munich, Germany., Bene MC; Hematology Biology, Nantes University Hospital, Nantes, France., Bettelheim P; Department of Hematology, Elisabethinen Hospital, Linz, Upper Austria, Austria., Brodersen LE; Hematologics, Inc., Seattle, Washington, USA., Burbury K; Peter MacCallum Cancer Centre, Melbourne, Australia., Chu SC; Department of Hematology and Oncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan., Cullen M; Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK., Porta MD; Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy., Dunlop AS; Department of Haematology, College Hospital London, London, England., Johansson U; Laboratory Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Matarraz S; Cytometry Service (NUCLEUS), Department of Medicine and IBSAL, Cancer Research Center (IBMCC, University of Salamanca-CSIC), Salamanca, Spain and Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain., Oelschlaegel U; Department of Internal Medicine, University Hospital of Technical University Dresden, Dresden, Germany., Ogata K; Metropolitan Research and Treatment Centre for Blood Disorders (MRTC Japan), Tokyo, Japan., Porwit A; Division of Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Preijers F; Department of Laboratory Medicine, Laboratory of Hematology, Radboudumc, Nijmegen, The Netherlands., Psarra K; Immunology Histocompatibility Department, Evangelismos Hospital, Athens, Greece., Saft L; Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital and Institute, Stockholm, Sweden., Subirá D; Department of Medical Immunology, Hospital Universitario de Guadalajara, Guadalajara, Spain., Weiß E; MLL Munich Leukemia Laboratory, Munich, Germany., van der Velden VHJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., van de Loosdrecht A; Department of Hematology, Amsterdam University Medical Centers, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2023 Jan; Vol. 104 (1), pp. 51-65. Date of Electronic Publication: 2022 Nov 23.
Autor:
Dumas PY; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, F-33000 Bordeaux, France; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Univ. Bordeaux, F-33000 Bordeaux, France. Electronic address: pierre-yves.dumas@u-bordeaux.fr., Bertoli S; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; Cancer Research Center of Toulouse, UMR1037 INSERM, ERL5294 CNRS, Toulouse, France., Bonmati C; Service d'Hématologie, CHU Nancy Brabois, 54500 Vandoeuvre les Nancy, France., Carre M; Service d'Hématologie clinique, CHU Grenoble Alpes, 38700 La Tronche, France., Lambert J; Service d'Hématologie, CH de Versailles, 78150 Le Chesnay, France., Ojeda-Uribe M; GHRMSA, Hôpital E Muller, Service d'Hématologie Clinique et Unité de Thérapie Cellulaire, 68070 Mulhouse, France., Chantepie S; Service d'Hématologie, CHU de Caen, 14000 Caen, France., Paul F; Départment d'Hématologie clinique, CHU de Montpellier, 34905 Montpellier, France., Jourdan E; Hématologie Clinique, Institut de Cancérologie du Gard - CHU de Nîmes, 30029 Nîmes, France., Haiat S; Service d'Hématologie, CH Sud Francilien, 91106 Corbeil Essonnes, France., Tavernier E; Institut de Cancérologie Lucien Neuwirth, 42270 Saint-Priest-en-Jarez, France., Peterlin P; Service d'Hématologie clinique, Nantes University Hospital, Nantes, France., Marolleau JP; Service d'Hématologie clinique et Thérapie cellulaire, CHU Amiens-Picardie, Amiens, France., Laribi K; Department of Hematology, Centre Hospitalier Le Mans, Le Mans, France., Orvain C; CHU d'Angers, Maladies du Sang, Angers, France; Univ Angers, Inserm, CRCINA, F-49000 Angers, France., Cabrera Q; CHU Réunion Sud - Site de Saint-Pierre, Saint-Pierre, France., Turlure P; Service d'Hématologie et Thérapie Cellulaire du CHU Dupuytren, Limoges, France., Girault S; Service d'Hématologie, CH de Brive, Brive, France., Balsat M; Service d'Hématologie, Hospices civils de Lyon, Lyon, France., Bernard M; Service d'Hématologie clinique, CHU de Rennes, Rennes, France., Bene MC; Service d'Hématologie Biologique, Nantes, France., Pigneux A; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, F-33000 Bordeaux, France; BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Univ. Bordeaux, F-33000 Bordeaux, France., Dombret H; Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Institut de Recherche Saint-Louis, Université de Paris, Paris, France., Récher C; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; Cancer Research Center of Toulouse, UMR1037 INSERM, ERL5294 CNRS, Toulouse, France. Electronic address: recher.christian@iuct-oncopole.fr.
Publikováno v:
Leukemia research [Leuk Res] 2022 Sep; Vol. 120, pp. 106901. Date of Electronic Publication: 2022 Jun 20.
Autor:
Tettero JM; Department of Hematology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Freeman S; Department of Clinical Immunology, Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, United Kingdom., Buecklein V; Department of Medicine III, University Hospital, LMU Munich, Germany., Venditti A; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Maurillo L; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy., Kern W; MLL Munich Leukemia Laboratory, Munich, Germany., Walter RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Wood BL; Department of Pathology and Laboratory Medicine, Childrens Hospital Los Angeles, California, USA., Roumier C; Laboratory of Hematology, CHU Lille, France., Philippé J; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium., Denys B; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium., Jorgensen JL; Department of Hematopathology, UT MD Anderson Cancer Center, Houston, Texas, USA., Bene MC; Hematology Biology, Nantes University Hospital, Nantes, France., Lacombe F; Flow Cytometry Platform, University Hospital, Bordeaux, France., Plesa A; Laboratory of Hematology and Flow Cytometry, CHU Lyon-Sud Hospital, Hospices Civils de Lyon, France., Guzman ML; Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, USA., Wierzbowska A; Department of Hematology, Medical University of Lodz, Poland., Czyz A; Department of Hematology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland., Ngai LL; Department of Hematology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Schwarzer A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Bachas C; Department of Hematology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Cloos J; Department of Hematology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Germany., Fuering-Buske M; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Buccisano F; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Publikováno v:
HemaSphere [Hemasphere] 2021 Dec 22; Vol. 6 (1), pp. e676. Date of Electronic Publication: 2021 Dec 22 (Print Publication: 2022).
Autor:
Foucault A; Department of Biological Hematology, Tours University Hospital, Tours, France.; CNRS ERL7001 LNOX, EA 7501, Tours University, Tours, France., Vallet N; Department of Hematology and Cell Therapy, Tours University Hospital, Tours, France., Ravalet N; Department of Biological Hematology, Tours University Hospital, Tours, France.; CNRS ERL7001 LNOX, EA 7501, Tours University, Tours, France., Picou F; Department of Biological Hematology, Tours University Hospital, Tours, France.; CNRS ERL7001 LNOX, EA 7501, Tours University, Tours, France., Bene MC; Department of Biological Hematology, Nantes University Hospital, Nantes, France., Gyan E; CNRS ERL7001 LNOX, EA 7501, Tours University, Tours, France.; Department of Hematology and Cell Therapy, Tours University Hospital, Tours, France., Herault O; Department of Biological Hematology, Tours University Hospital, Tours, France. olivier.herault@univ-tours.fr.; CNRS ERL7001 LNOX, EA 7501, Tours University, Tours, France. olivier.herault@univ-tours.fr.
Publikováno v:
Scientific reports [Sci Rep] 2021 Jan 21; Vol. 11 (1), pp. 2007. Date of Electronic Publication: 2021 Jan 21.
Autor:
Ravalet N; Department of Biological Hematology, Tours University Hospital, 37000 Tours, France.; CNRS ERL 7001 LNOX, EA7501, Faculty of Medidine, Tours University, 37000 Tours, France., Foucault A; Department of Biological Hematology, Tours University Hospital, 37000 Tours, France.; CNRS ERL 7001 LNOX, EA7501, Faculty of Medidine, Tours University, 37000 Tours, France., Picou F; Department of Biological Hematology, Tours University Hospital, 37000 Tours, France.; CNRS ERL 7001 LNOX, EA7501, Faculty of Medidine, Tours University, 37000 Tours, France., Gombert M; Department of Biological Hematology, Tours University Hospital, 37000 Tours, France., Renoult E; Department of Biological Hematology, Tours University Hospital, 37000 Tours, France., Lejeune J; Department of Hematology and Cell Therapy, Tours University Hospital, 37000 Tours, France., Vallet N; Department of Hematology and Cell Therapy, Tours University Hospital, 37000 Tours, France., Lachot S; Department of Biological Hematology, Tours University Hospital, 37000 Tours, France., Rault E; Department of Biological Hematology, Tours University Hospital, 37000 Tours, France., Gyan E; CNRS ERL 7001 LNOX, EA7501, Faculty of Medidine, Tours University, 37000 Tours, France.; Department of Hematology and Cell Therapy, Tours University Hospital, 37000 Tours, France., Bene MC; Department of Biological Hematology, Nantes University Hospital, 44000 Nantes, France., Herault O; Department of Biological Hematology, Tours University Hospital, 37000 Tours, France.; CNRS ERL 7001 LNOX, EA7501, Faculty of Medidine, Tours University, 37000 Tours, France.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Jan 21; Vol. 13 (3). Date of Electronic Publication: 2021 Jan 21.
Autor:
Vignon C; CNRS ERL7001 LNOx 'Leukemic Niche & redox metabolism' and EA7501 GICC, Tours University, Tours, France., Lachot S; Tours University Hospital, Department of Biological Hematology, Tours, France., Foucault A; CNRS ERL7001 LNOx 'Leukemic Niche & redox metabolism' and EA7501 GICC, Tours University, Tours, France.; Tours University Hospital, Department of Biological Hematology, Tours, France., Ravalet N; CNRS ERL7001 LNOx 'Leukemic Niche & redox metabolism' and EA7501 GICC, Tours University, Tours, France.; Tours University Hospital, Department of Biological Hematology, Tours, France., Gyan E; CNRS ERL7001 LNOx 'Leukemic Niche & redox metabolism' and EA7501 GICC, Tours University, Tours, France.; Tours University Hospital, Department of Hematology and Cell Therapy, Tours, France., Picou F; CNRS ERL7001 LNOx 'Leukemic Niche & redox metabolism' and EA7501 GICC, Tours University, Tours, France.; Tours University Hospital, Department of Biological Hematology, Tours, France., Herault B; French Blood Establishment (EFS) Centre-Pays de la Loire, Tours, France., Le Nail LR; Tours University Hospital, Department of Orthopedic Surgery 2, Tours, France., Bene MC; Nantes University Hospital, Hematology Biology & CIRCNA, Nantes, France., Herault O; CNRS ERL7001 LNOx 'Leukemic Niche & redox metabolism' and EA7501 GICC, Tours University, Tours, France.; Tours University Hospital, Department of Biological Hematology, Tours, France.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2020 Nov; Vol. 98 (6), pp. 516-521. Date of Electronic Publication: 2020 Sep 04.
Autor:
Jullien M; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France. maxime.jullien@chu-nantes.fr., Guillaume T; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Peterlin P; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Garnier A; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Le Bourgeois A; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Debord C; Hematology Biology, Nantes University Hospital, Nantes, France., Mahe B; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Dubruille V; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Wuilleme S; Hematology Biology, Nantes University Hospital, Nantes, France., Blin N; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Touzeau C; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Gastinne T; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Tessoulin B; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Le Bris Y; Hematology Biology, Nantes University Hospital, Nantes, France., Eveillard M; Hematology Biology, Nantes University Hospital, Nantes, France., Duquesne A; EFS de Nantes, Nantes, France., Moreau P; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Le Gouill S; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France., Bene MC; Hematology Biology, Nantes University Hospital, Nantes, France., Chevallier P; Clinical Hematology, Nantes University Hospital, CHU de Nantes, 1 Place Alexis Ricordeau, 44000, Nantes, France.
Publikováno v:
Scientific reports [Sci Rep] 2020 Sep 21; Vol. 10 (1), pp. 15399. Date of Electronic Publication: 2020 Sep 21.